MULTIPURPOSE IMPLANT WITH MODELED SURFACE STRUCTURE
20210068938 ยท 2021-03-11
Inventors
- Viacheslav Agarkov (Aliso Viejo, CA, US)
- Igor Uspenskiy (Nizhniy Novgorod, RU)
- Yury Kolmogorov (Nizhniy Novgorod, RU)
Cpc classification
A61F2/30767
HUMAN NECESSITIES
A61F2002/3071
HUMAN NECESSITIES
A61F2002/0081
HUMAN NECESSITIES
A61F2002/30772
HUMAN NECESSITIES
A61L2400/18
HUMAN NECESSITIES
A61F2/30771
HUMAN NECESSITIES
A61F2/0063
HUMAN NECESSITIES
A61F2250/0018
HUMAN NECESSITIES
A61F2002/009
HUMAN NECESSITIES
A61F2/0077
HUMAN NECESSITIES
C08L67/04
CHEMISTRY; METALLURGY
C08L67/04
CHEMISTRY; METALLURGY
A61F2002/0086
HUMAN NECESSITIES
A61F2/30965
HUMAN NECESSITIES
International classification
A61F2/00
HUMAN NECESSITIES
Abstract
Embodiments of an implant for use in surgery are disclosed. The implant may include elastic polymer file made from a suitable biologically compatible polymer. The implant may also include a reinforcement element.
Claims
1. A surgical implant for reconstruction of soft tissues comprising: an elastic film formed from a non-porous biologically compatible cross-linked copolymer based on 50-75 percent by weight multi-functional urethane (meth)acrylate oligomers and 20-50 percent by weight methacrylate monomers; the elastic film having: a first smooth anti-adhesive surface, and a second relief surface opposite the first surface, the second surface having indentations, and a reinforcement element in a form of a woven synthetic mesh enclosed inside the elastic film, wherein the reinforcement element is covered with the elastic film across an entire first smooth anti-adhesive surface area of the implant and wherein portions of the reinforcement element are exposed through the indentations of the second relief surface.
2. The surgical implant of claim 1, wherein the first smooth surface has a roughness that does not exceed about 50 nanometers.
3. The surgical implant of claim 1, wherein the reinforcement element comprises polypropylene mesh.
4. The surgical implant of claim 1, wherein the reinforcement element comprises polyester mesh.
5. The surgical implant of claim 1, wherein the elastic film has the oval shape.
6. The surgical implant of claim 1, wherein the elastic film has the shape of a rectangle with rounded corners.
7. The surgical implant of claim 1, wherein the elastic film is continuous without holes or apertures such that the reinforcement element is covered with the film across the entire first smooth anti-adhesive surface area of the implant.
8. The surgical implant of claim 1, wherein the elastic film comprises holes through the film in an area of the indentations of the second relief surface.
9. The surgical implant of claim 1, wherein the elastic film comprises an inscription for indication of film surfaces.
10. The surgical implant of claim 1, wherein the implant comprises openings with pre-installed polypropylene filaments for fixation of the implant.
11. The surgical implant of claim 1, wherein the cross-linked copolymer comprises 50-70 weight percent of oligourethane methacrylate and 1-5 weight percent of octyl methacrylate and 25-40 weight percent of benzyl methacrylate.
12. The surgical implant of claim 1, wherein the elastic film is processed by soaking in suitable solvent selected from: methanol, propanol, i-propanol, propanone, water or the mixture of them.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0031] Embodiments of the present application will now be described hereinafter, by way of example only, with reference to the accompanying drawings in which:
[0032]
[0033]
[0034]
[0035]
[0036]
[0037]
[0038]
[0039]
[0040]
[0041]
[0042]
[0043]
[0044]
[0045]
[0046]
[0047]
[0048]
DETAILED DESCRIPTION
[0049] While certain embodiments are described, these embodiments are presented by way of example only, and are not intended to limit the scope of protection. Indeed, the novel methods and systems described herein may be embodied in a variety of other forms. Furthermore, various omissions, substitutions, and changes in the form of the methods and systems described herein may be made without departing from the scope of protection.
[0050]
[0051]
[0052] The embossed surface (4) can include a pattern of a preset size, depth and cell (or pore) shape. For example, the pattern can include cells measuring about 75 m (microns) by about 75 m and be about 50 m deep. As another example, the cells can measure about 75 m in diameter and be about 50 m deep. The cells can have circular, rectangular, hexagonal, or any other suitable shape and can be of any suitable size. The pattern may include cells of more than size and shape. For example, the embossed pattern can be in the form of a mesh, numbers, letters or their combination. The embossed pattern can be regular (e.g., not open-ended). The embossed surface can facilitate fixation to adjacent tissue.
[0053]
[0054]
[0055] In some embodiments, the reinforcement element can cover or be embedded in less than the entire surface area of the implant. For example, the implant can include one or more reinforcement element sections. Sections of the reinforcement element can have any suitable shape, such as square, rectangular, circular and radial strip shape. In some embodiments, sections of the reinforcement element can be covered with film on both sides, with the film covering not only synthetic material but also portions extending between sections of the reinforcement element. The film may have the same texture as sections of the implant that do not include the reinforcement element inside the film. In other embodiments, sections of the reinforcement element can be covered with film having different smoothness or texture as sections of the implant that do not include the reinforcement element inside the film. For example, sections of the reinforcement element can be covered with smooth film while other sections of the implant that do not include the reinforcement element have textured film.
[0056]
[0057]
[0058]
[0059]
[0060]
[0061]
[0062]
[0063]
[0064]
[0065]
[0066]
[0067]
[0068] The
[0069] The
[0070] As shown, the second relief surface (4) may position the indentations (3) through the reinforcement element (1), such that the reinforcement element (1) is not fully enclosed. The indentations (3) may be any shape, such as rectangular, square, circular, ovoid, etc. and may be uniform along the depth or may be tapered. A reinforcement layer (1) is integrated with the elastic film that portions of the reinforcement layer (1) are exposed through the indentations (3) of second relief surface (4). In an exemplary embodiment, both sides of the reinforcement layer (1) are exposed at the indentations (3). The reinforcement layer (1) is traverses through all of the indentations (3).
[0071] As shown, the textured surface may position the indentations through the reinforcement element, such that the reinforcement element is not fully enclosed. The textured surface may also permit gaps or space to be formed between the one surface (3) and the reinforcement element (1). For example, the implant may include a solid layer, in which a first side of the solid layer defines a smooth surface and a second side of the solid layer defines a textured surface. The textured surface may comprise indentations. The indentations may be any shape, such as rectangular, square, circular, ovoid, etc. and may be uniform along the depth or may be tapered. A reinforcement layer may be integrated with the solid layer such that portions of the reinforcement layer are exposed through the indentations of the textured surface. In an exemplary embodiment, both sides of the reinforcement layer are exposed at the indentations. The reinforcement layer may traverse through all of the indentations or a portion of the indentations. As shown, a partial perimeter of indentations defining the textured surface may extend around a peripheral edge of the implant, where the partial perimeter of indentations does not include a reinforcing layer. The reinforcing layer may also be textured or provide apertures through the reinforcing layer or may be solid.
[0072] In an exemplary embodiment, the reinforcement layer may be a woven, solid, or apertured structure. When the reinforcement layer is exposed through the textured surface, the reinforcement layer may form spaces for tissue ingrowth. For example, the reinforcement layer may provide apertures that permit access to the space between the reinforcement layer and the one surface and other apertures in the reinforcement layer to exit the space between the reinforcement layer and the one surface, thereby creating a member for the tissue to hook to. In an exemplary embodiment, portions of the reinforcement layer may be colored or otherwise provide a pattern that is visible or can be felt through the outer surfaces to orient or align the implant during use.
[0073] Exemplary embodiments of the multi-purpose surgical implant are formed from an elastic film formed from a non-porous biologically compatible cross-linked copolymer based on 50-75 percent by weight multi-functional urethane (meth)acrylate oligomers and 20-50 percent by weight methacrylate monomers. The elastic film may have a first smooth anti-adhesive surface, and a second relief surface opposite the first surface. The elastic film may be processed by soaking in isopropyl alcohol so as to block residual free radicals, thereby decreasing a risk of tissue reaction. The surgical implant may also have a reinforcement element partially or fully enclosed inside the elastic film, wherein the reinforcement element does not contact body organs and tissue from the side of the first smooth anti-adhesive surface. The reinforcement layer may comprise a plurality of apertures. In an exemplary embodiment, adjacent apertures and an intermediate reinforcement layer portion connecting the adjacent apertures may be exposed through the elastic film. In an exemplary embodiment, the elastic film forms a continuous surface on one entire side of the reinforcement layer. In an exemplary embodiment, the reinforcement layer is raised above an exposed surface of the elastic film. The reinforcement layer may have protrusions supporting and extending through the reinforcement layer to partially encapsulate a portion of the reinforcement layer and to expose a portion of the reinforcement layer. In an exemplary embodiment, a gap is formed between the reinforcement layer and the elastic film continuous layer.
[0074] The invention also relates to a method for manufacturing an artificial elastic implant for restorative and reconstructive surgery, comprising two casting steps performed in a casting mold. The mold has at least a cover (1) that is optically and UV transparent. In a first step, a first layer of a first photo-curable material or of a second photo-curable material is cast while forming a meniscus (4). Using one of two photo masks (5), the mold is irradiated with UV light to cure the first layer. In a second step, a second layer of either the first or the second photo-curable material is cast onto the cured first layer while forming a meniscus. After irradiating the mold again with ultraviolet light, unhardened photo-curable material is re-moved from the product by dissolving in a suitable solvent. After additionally irradiating the product with UV light, the product is soaked, separated from the mold, placed in isopropyl alcohol for 3 to 24 hours and then vacuum dried.
[0075] The first photo-curable material is a composition comprising: [0076] 25-40 wt.-% benzyl methacrylate [0077] 50-70 wt.-% oligourethane methacrylate [0078] 1-5 wt.-% methacrylic acid [0079] 1-5 wt.-% octyl methacrylate.
[0080] The second photo-curable material is a composition comprising: [0081] 20-30 wt.-% phenoxyethyl methacrylate [0082] 20-30 wt.-% oligourethane methacrylate 1000F [0083] 35-45-wt.-% oligourethane methacrylate 5000F [0084] 1-5 wt.-% methacrylic acid [0085] 1-5 wt.-% ethylene glycol monomethacrylate.
[0086] The invention also relates to a method for manufacturing a surgical implant for reconstruction of soft tissues, comprising several casting steps performed in a casting molds. Each mold consists of two plane glasses; at least one of the glass is cover with photomask. The UV irradiation through photomask forms the structure on the product i.e. the size, form, numbers, letters, meshes, shapes corresponding to the embossed pattern on the surface of the formed product. If the layer contains reinforcing material than the material must be placed on the glass with the photomask to be and irradiated through it. After irradiating the mold is to be decoupled, and the photo-curable material may be poured on the previous layer. Then the molding form is to be covered with the glass with the photomask, suitable to form the next layer. After the last irradiating the mold is to be decoupled and unhardened photo-curable material is re-moved from the product by dissolving in a suitable solvent. Suitable solvents include without being limited to, lower alcohols like ethanol, methanol, propanol, i-propanol, ketones like propanone, 4-methyl-pentan-2-one and butanone as well as mixture s of these.
[0087] The photo-curable material is a composition comprising:
[0088] 20-45 wt.-% benzyl methacrylate
[0089] 50-70 wt.-% oligourethane methacrylate
[0090] 1-5 wt.-% methacrylic acid
[0091] 1-5 wt.-% octyl methacrylate.
[0092] The oligourethane methacrylate may have the following structure:
##STR00001##
[0093] The formulation advantageously contains other ingredients that are common in the field of photocurable materials. These are for example effective amounts of additives capable of initiation of radical polymerization, optical sensitization and/or inhibiting thermal polymerization, dyes or pigments, stabilizers, and the like. Examples are azo-bis-isobutyronitrile, 3,5-di-t-butyl-o-quinone, 2,2-dimethoxyphenyl acetophenone, 2,6-di-tert-butyl-4-metylphenol.
[0094] In order to remove all residual monomers, which are left in the cured material and could irritate surrounding tissue after implantation, the polymer is to be irradiated with UV light. Then the polymer must be cured in solvent such as methanol, propanol, i-propanol, propanone, water or the mixture of them at the temperature from 30 C. to 100 C. during 300-1000 min. After drying, the product is ready.
[0095] The technical problem to be solved by the invention includes developing a method that allows to produce an implant, which has high elasticity and minimal impact on the surrounding organs and tissues, which has a high biological stability and providing for a reactivity in the post-operative period. The method should also allow producing implants having a uniform surface, either smooth or structured, as well as implants having different partial surfaces, like one smooth and one structured.
[0096] This technical problem is solved by a method in accordance with claim 1.
[0097] Most of the ingredients used in the method of this invention are commercially available chemicals well-known to the skilled person in the field of polymers. For the oligourethans the following structures apply:
[0098] Oligourethane methacrylate 1000F of the following structure:
##STR00002##
[0099] Oligourethane methacrylate 5000F of the following structure:
##STR00003##
[0100] The casting mold, at least the cover, is made from a material which is transparent for visible light as well as UV light in the spectral region needed for photo polymerization. Suitable materials are
[0101] UV transparent glass, plastic. The cover can accommodate the photomask into a suitable cavity. The base and the limiting ring can as well be made from other materials like metal, ceramics, plastic. In the present method the mold is not completely filled by the photo polymerizable material. Moreover the material forms a meniscus in its upper region. A meniscus is a free surface of liquid, the shape of which forms under the influence of gravity and the surface energies of the surfaces involved. The surface of the meniscus will remain very smooth during first curing.
[0102] It should be noted, that pouring on the material takes place before the limiting ring is being placed on to the base. That means that the amount of photo polymerizable material must be small enough to avoid the material flowing to the rim of the base and from there down.
[0103] The photomask is either the first photomask defining the outer geometrical dimensions of the product to be formed, for example a circular, elliptical or square shape, or the second photomask, which on irradiation forms the structure on the surface of the product and is in the form of numbers, letters, meshes, shapes corresponding to the embossed pattern on the surface of the formed product.
[0104] After closing the mold it is irradiated with UV light suitable to photo-cure the material. In this first irradiation it is intended to cure the material all the way from top to bottom of the layer. After irradiation the cover and limiting ring are removed and again photo polymerizable material is being poured onto the object just formed, again while forming a meniscus. The mold is again closed and irradiated. This time the photomask is the stencil for the intended surface structure of the product. This may for example be a pattern of shallow dimples or narrow ribs which are to improve the adherence of growing tissue after implantation. It may also be in the form of numbers, letters, meshes, shapes corresponding to the embossed pattern on the surface of the formed product Alternately the first photomask could be used as well in the second step.
[0105] After the mold has been opened, excess unhardened photocurable material is being removed by dissolving it in a suitable solvent. In this step the final shape of the product is determined. Suitable solvents include without being limited to, lower alcohols like ethanol, methanol, propanol, i-propanol, ketones like propanone, 4-methyl-pentan-2-one and butanone as well as mixture s of these.
[0106] In order to remove all residual monomers which are left in the cured material and could irritate surrounding tissue after implantation, a final UV exposure is now done, followed by soaking the product in hot water of 90 to 100 C. for at least 30 min.
[0107] Up to now the product was still adhered to the mold base. It is now separated from the base and placed in the closed container with Isopropanol at the temperature of between 22 and +12 C. for 3 to 24 hours. After vacuum drying the product is ready.
[0108] The formulation of the photocurable material is based upon acrylates and is as follows:
[0109] The first photo-curable material is a composition comprising [0110] 25-40 wt.-% benzyl methacrylate [0111] 50-70 wt.-% oligourethane methacrylate [0112] 1-5 wt.-% methacrylic acid [0113] 1-5 wt.-% octyl methacrylate.
[0114] The second photo-curable material is a composition comprising [0115] 20-30 wt.-% phenoxyethyl methacrylate [0116] 20-30 wt.-% oligourethane methacrylate 1000F [0117] 35-45-wt.-% oligourethane methacrylate 5000F [0118] 1-5 wt.-% methacrylic acid [0119] 1-5 wt.-% ethylene glycol monomethacrylate.
[0120] The optimal composition has to be determined by pretests.
[0121] The formulation advantageously contains other ingredients which are common in the field of photocurable materials. These are for example effective amounts of additives capable of initiation of radical polymerization, optical sensitization and/or inhibiting thermal polymerization, dyes or pigments, stabilizers, and the like. Examples are 3, 5-di-t-butyl-o-quinone, azo-bis-isobutyronitrile, 3, 5-di-t-butyl-o-quinone and/or 2, 2-dimethoxyphenylacetophenone. [0022] The invention will be further explained by means of the accompanying drawings, which show specific embodiments of the mold used.
[0122] An exemplary mold consists of a base, a cover, and the limiting ring. The upper part of the mold is equipped with a photomask, which is protected by PET-film. A photocurable material is poured onto the base and forms the meniscus on its upper surface.
[0123] To manufacture elastic artificial implants for restorative and reconstructive surgery, a casting mold is used consisting of two parts made e. g. of optically transparent material such as glass.
[0124] Onto the lower part of the mold the first photo-curable material is poured, consisting of: [0125] benzyl methacrylate31.68 wt. %; [0126] methacrylic acid1.97 wt. %; [0127] octyl methacrylate1.97 wt. %; [0128] dinitrilazo-bis-isobutyric acid0.005 wt. %; [0129] 2, 2-dimethoxy-phenylacetophenone0.88 wt. %; [0130] 3, 5-di-t-butyl-o-quinone0.01 wt. %; [0131] inorganic pigment ultramarine 4631.0 wt. %; [0132] oligourethane methacrylatethe rest,
with the formation of the upper meniscus. The base is covered with the upper part of the mold, in which the limiting ring and the photo-mask corresponding to the outer geometrical dimensions of the product to be formed and protected by the PET-film are fixed to the cover. The two parts of the mold are firmly pressed together and irradiated with UV light, the wave length being 360-380 nm, all over the entire surface of the upper part of the mold. The irradiation time is determined empirically so that the curing of the photosensitive composition takes place all the way through the depth of the layer. Then the parts of the mold are separated and onto the lower part of the mold with the layer that has just been formed, the second liquid photosensitive material is poured forming the meniscus, the composition of the second material being: [0133] oligourethane methacrylate 1000F25.8 wt. %, [0134] phenoxyethyl methacrylate25.6 wt. %, [0135] methacrylic acid4.46 wt. %, [0136] mono methacrylic ethylene glycol ether4.46 wt. %, [0137] dinitrilazo-bis-isobutyric acid0.005 wt. %, [0138] 2, 2-dimethoxy-phenylacetophenone0.775 wt. %, [0139] 3, 5-di-t-butyl-o-quinone0.01 wt. %, [0140] oligourethane methacrylate 5000Fthe rest.
[0141] The base is covered with the upper part of the mold on which are fixed the limiting ring and the photo-mask having transparent and opaque areas in the form of numbers, letters, meshes, shapes corresponding to the embossed pattern formed on the surface of the product, protected by PET-film. The two parts of the mold are then firmly pressed together and the mold is irradiated all over the entire surface of the upper part of the mold. Then the mold parts are separated. The product stays on the base of the mold with the remnants of the uncured liquid material that during the time of irradiation was under the opaque areas of the photo-mask. The product is carefully developed in a suitable solvent such as isopropyl alcohol, then the resulting product, without separating it from the mold, is additionally irradiated with UV light for 3-10 minutes in bi-distilled water at T=40-60 C. Then the mold is additionally placed into a container with bi-distilled water and is soaked for 30-45 minutes at a constant T=100 C. Next, the product is separated from the mold and placed in a closed container with isopropyl alcohol for 3-24 hours at the temperature of 20 C to +12 C., after which the product undergoes a thermal vacuum drying at 40-70 C. for 1-6 hours.
[0142] This way it is possible to make implants that have two types of surfaces different in structure (
[0143] The following working examples and application tests are a further illustration of the method of the invention:
[0144] Example 1. To manufacture elastic artificial implants for restorative and reconstructive surgery a casting mold is used consisting of two parts made of glass (
[0145] Onto the lower part 2 of the mold a first light-sensitive material 4 (number 1) is poured, consisting of:
TABLE-US-00001 benzyl methacrylate 31.68 wt. %; methacrylic acid 1.97 wt. %; octyl methacrylate 1.97 wt. %; dinitrilazo-bis-isobutyric acid 0.005 wt. %; 2,2-dimethoxy-phenylacetophenone 0.88 wt. %; 3,5-di-t-butyl-o-quinone 0.01 wt. %; inorganic pigment ultramarine 463 1.0 wt. %; oligourethane methacrylate the rest,
whereby an upper meniscus is formed (
TABLE-US-00002 oligourethane methacrylate 1000F 25.8 wt. %; phenoxyethyl methacrylate 25.6 wt. %; methacrylic acid 4.46 wt. %; mono methacrylic ethilene glycol ether 4.46 wt. %; dinitrilazo-bis-isobutyric acid 0.005 wt. %; 2,2-dimethoxy-phenylacetophenone 0.775 wt. %; 3,5-di-t-butyl-o-quinone 0.01 wt. %; oligourethane methacrylate 5000F the rest.
[0146] The lower part 2 of the mold is covered with the upper path on which are fixed the limiting ring 3 and the photo-mask 5 (
[0147] Patient Z., female, born 1947, admitted to hospital 25 Jan. 2008 MLPU City Clinical Hospital No 39 of the city of Nizhny Novgorod, with a diagnosis of meningeoma in the left frontal region. 29 Jan. 2008 the patient underwent resection craniotomy, the meningeoma was removed. As a result of the removal of the tumor originating from the dura mater, a 33 cm defect of the dura mater was formed. The plasty of the defect was performed using plastic implants for the dura mater plastic defects. The postoperative period went without complications. 13 Feb. 2008 the patient was discharged to outpatient treatment.
[0148] Example 2. An artificial elastic implant for restorative and reconstructive surgery is made as in Example 1, but, before the developing takes place, onto the lower part of the mold with the layer that has just been formed, the liquid photosensitive material number 1 is poured to form a meniscus. In this way an implant is produced, which has surfaces different in structure but identical in elasticity (
[0149] Patient K., male, age 43 was hit by a car Oct. 4, 2008 and admitted to MLPU City Clinical Hospital No 39. The MR-tomograms of the patient revealed an acute subdural hematoma in the right fronto-temporo-parietal region, causing a 4 mm dislocation of the brain to the left. Oct. 5, 2008 the patient underwent resection craniotomy in the right temporo-parietal region, and the removal of acute subdural hematoma. After the removal of the subdural hematoma, the brain spread out into the burr window, which formed a TMO defect. Plasty using the implant in question was performed. In the immediate postoperative period the patient's condition slightly improved: the restoration of consciousness to a deep stunning. But 8 days later the patient re-booted into the 1st stage coma. MR-tomography was done again. It revealed a delayed injurya bruise and crush of the left temporal lobe, causing dislocation of midline structures to the right by 3 mm. Oct. 13, 2008 the patient was subjected to decompressive craniotomy in the left temporo-parietal region, removing the source of injurya bruise and crush of the left temporal lobe. Plasty of TMO using the implant in question was performed as well. The postoperative period was uneventful. The patient's condition gradually improved and on November 21 in a satisfactory condition he was discharged for outpatient treatment to a neurologist. In the neurological status moderate cognitive and mnestic violations were retained. Feb. 10, 2009 the patient was re-hospitalized for cranioplasty. February 14th the patient underwent Xeno-cranioplasty in both temporo-parietal regions. It should be noted that between the brain, the implant and the overlying soft tissues no scar adhesions had formed, due to which the surgery duration was decreased.
[0150] Example 3. An artificial elastic implant for restorative and reconstructive surgery is made as in Example 1, but, before superimposing the upper part of the mold on the lower part of the mold, the liquid photosensitive material number 2 is poured to form the meniscus. This way we receive an implant that has surfaces different in structure but identical in elasticity (
[0151] Example 4. An artificial elastic implant for restorative and reconstructive surgery is made as in Example 1, but, before superimposing the upper part of the mold on the lower part of the mold, liquid photosensitive material number 1 is poured together with the meniscus, then it is covered with the upper part of the mold on which are fixed the limiting ring and the photo-mask having transparent and opaque areas in the form of numbers, letters, meshes, shapes corresponding to the embossed pattern formed on the surface of the product, protected by PET-film, the two parts of the mold firmly pressed together, irradiated all over the entire surface of the upper part of the mold. This way we get an implant having a surface structure that could be penetrated by the connective tissues of the body; this implant can be used, for example, in the surgery of inguinal hernias according to the method of Lichtenstein, to reduce the trauma of tissues and to provide for a reactivity in the post-operative period.
[0152] Patient S., male, age 52, admitted to MLPU City Hospital No 35 28 Oct. 2007 by emergency service. He was brought in by an emergency team with complaints of severe pain in the right inguinal region, repeated vomiting, the presence of a painful protrusion of the right groin. On examination, he was diagnosed with incarcerated inguinal-scrotal hernia on the right. Based on these emergency indications a surgery was performedherniotomy using the above-described implant. Smooth post-operative period. Healing by first intention. Suppuration, seromas, infiltrates and fistula were not noted. Discharged in satisfactory condition on day 7. Examined in six weeks. The plasty zone was consistent. No signs of relapse of hernia. An ultrasound scan of the implantation area revealed no liquid formation. The implant was without signs of deformation or dislocation.
[0153] Example 5. An artificial elastic implant for restorative and reconstructive surgery is made as in Example 1, but, before superimposing the upper part of the mold on the lower part of the mold, liquid photosensitive material number 2 is poured to form a meniscus, then it is covered with the upper part of the mold on which are fixed the limiting ring and the photo-mask having transparent and opaque areas in the form of numbers, letters, meshes, shapes corresponding to the embossed pattern formed on the surface of the product, protected by PIT-film, the two parts of the mold firmly pressed together, irradiated all over the entire surface of the upper part of the mold. This way we get an implant having a surface structure that could be penetrated by the connective tissues of the body; this implant can be used, for example, in the surgery of inguinal hernias according to the method of Trabucco, to reduce the trauma of tissues and to provide for a reactivity in the post-operative period.
[0154] Patient B., male, age 57, was admitted on an emergency basis with severe pain in the left inguinal region. He reported that he had had a bilging in this area for many years, which of yesterday stopped going back into the abdomen and became acutely painful. When examined at MLPU City Hospital No 35, 28 Nov. 2007, he was diagnosed with incarcerated inguinal-scrotal hernia on the left. Based on these emergency indications a surgery was performedherniotomy using the above-described implant. Postoperative period went without complications. Seromas, suppuration, infiltration in the area of operations was not observed. The wound healed by first intention. Discharged in a satisfactory condition on day 6.
[0155] Example 6. An artificial elastic implant for restorative and reconstructive surgery is made as in Example 1, but after additional irradiation with UV light, the mold is additionally placed into a container of bi-distilled water at constant T=20 C. to soak for 30-45 minutes. Preclinical toxicity study of aqueous extract of the implant according to GOST R ISO 10993-11-2009 by ultraviolet spectroscopy showed the exceeding of the allowable values by 0.2 OP units (the maximum allowed OP value of the aqueous extract is 0.15). No clinical studies were conducted.
[0156] Example 7. An artificial elastic implant for restorative and reconstructive surgery is made as in Example 1, but after additional irradiation with UV light, the mold is additionally is placed into a container of bi-distilled water at constant T=100 C. to soak for 3 minutes. Preclinical toxicity study of aqueous extract of the implant according to GOST R ISO 10993-11-2009 by ultraviolet spectroscopy showed the exceeding of the allowable values by 0.12 OP units (the maximum allowed OP value of the aqueous extract is 0.15). No clinical studies were conducted.
[0157] In an example where the parameters of the method of manufacturing the implant correspond to the invention formula, the implants have high elasticity, a minimal impact on the surrounding organs and tissues, have both the same types of surfaces and the surfaces that vary in texture and smoothness, are of high biological stability, provide for a reactivity in the post-operative period. Deviations from the method that strictly follows the invention formula lead to the formation of the implant that does not have a low enough toxicity, which can have negative effects on living tissue.
[0158] Although the present disclosure includes certain embodiments, examples and applications, it will be understood by those skilled in the art that the present disclosure extends beyond the specifically disclosed embodiments to other alternative embodiments and/or uses and obvious modifications and equivalents thereof, including embodiments which do not provide all of the features and advantages set forth herein. For example, while